Today's AI Generated Day Trade/Scalping Watchlist 1/3/2025

\### Summary of Analysis Approach Total Tickers Analyzed: 57 The analysis focused on identifying stocks best suited for day trading and scalping by evaluating key criteria: \- \*\*Gap Analysis\*\*: Stocks with the highest post-market gap percentages were prioritized for their potential volatility. \- \*\*Volume Metrics\*\*: Stocks with a current volume significantly above their 10-day average were highlighted for their liquidity, which is crucial for quick trades. \- \*\*Technical Range Proximity\*\*: Stocks trading near their 52-week highs or lows were considered due to the potential breakouts or breakdowns. \- \*\*News Sentiment\*\*: Stocks with positive or negative news sentiment were flagged as potential catalysts for intraday price movements. \- \*\*Earnings Catalyst\*\*: Stocks with upcoming earnings within 14 days were noted for potential pre-earnings volatility. \- \*\*Price Action Consistency\*\*: A review of the past 10 days' price action and volume trends ensured consistent intraday movement patterns. \### Explanation for Stock Rankings 1. \*\*NITO (9.7)\*\* \- Highest Post-Market Gap at 39.25% indicating strong volatility. \- Significant volume increase at 253,985% over average, ensuring liquidity. \- Trading close to 52-week high with bullish news sentiment. \- Clean tech sector news acts as an additional catalyst. 2. \*\*CGBS (9.3)\*\* \- High Post-Market Gap at 9.11%. \- Volume surged by 385,420% over average. \- Positive news regarding strategic acquisitions and financial filings. \- Proximity to the lower end of 52-week low indicates possible bullish reversal. 3. \*\*SPCB (9.0)\*\* \- Post-Market Gap of 8.98% with high volume at 360,179% over average. \- Somewhat-bullish news sentiment. \- Recent analyst coverage could stir investor interest. 4. \*\*MBIO (8.9)\*\* \- Post-Market Gap of 2.92% and volume at 387,296% over average. \- Recent positive trial data for cancer treatment, driving upward momentum. \- Upcoming earnings within 14 days, adding to potential volatility. 5. \*\*REVB (8.8)\*\* \- Post-Market Gap of 3.5% and significant volume increase. \- Positive news on licensing and preclinical data. \- Upcoming earnings in 14 days could trigger pre-earnings movements. 6. \*\*TXMD (8.5)\*\* \- Post-Market Gap of 3.83% with volume 274,737% over average. \- Recent upgrades and merger news provide positive sentiment. \- Upcoming earnings within 14 days. 7. \*\*CRKN (8.3)\*\* \- Although the Post-Market Gap is slightly negative, the volume is astronomical compared to average. \- Recent customer acquisition news adds positive sentiment. \- Trading near the 52-week low could indicate a potential reversal. 8. \*\*CTCX (8.0)\*\* \- High volume increase, despite a negative Post-Market Gap. \- Bullish news sentiment from industry events can attract attention. 9. \*\*NMRA (7.8)\*\* \- Moderate Post-Market Gap with somewhat-bullish sentiment. \- Recent FDA clinical hold could create volatility. \- Trading far from 52-week high, but news on depressive disorder drug could be a positive catalyst. 10. \*\*REVBW (7.5)\*\* \- Despite a negative Post-Market Gap, the volume is significantly higher than average. \- Lack of news sentiment but technical levels may attract speculative trades. \### Additional Insights \- Stocks like \*\*NITO\*\* and \*\*CGBS\*\* show substantial momentum potential due to industry developments and technical setups. \- \*\*SPCB\*\* and \*\*MBIO\*\* benefit from substantial news catalysts that could influence short-term trading strategies. \- Monitoring upcoming earnings reports for \*\*MBIO\*\* and \*\*TXMD\*\* may provide opportunities for pre-earnings price movement plays.